Pfizer

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Trade Pfizer 24 hours a day, five days a week on Robinhood.

Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.

About PFE

Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide. The firm works across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases. 

CEO
Albert Bourla
CEOAlbert Bourla
Employees
81,000
Employees81,000
Headquarters
New York, New York
HeadquartersNew York, New York
Founded
1849
Founded1849
Employees
81,000
Employees81,000

PFE Key Statistics

Market cap
128.20B
Market cap128.20B
Price-Earnings ratio
16.30
Price-Earnings ratio16.30
Dividend yield
7.36%
Dividend yield7.36%
Average volume
50.22M
Average volume50.22M
High today
$23.16
High today$23.16
Low today
$21.75
Low today$21.75
Open price
$22.20
Open price$22.20
Volume
59.80M
Volume59.80M
52 Week high
$31.54
52 Week high$31.54
52 Week low
$21.75
52 Week low$21.75

PFE News

Simply Wall St 2d
Pfizer Involved In Lawsuit Over US$45 Per Share Cerevel Acquisition

In recent developments, a class action lawsuit was filed against Cerevel Therapeutics, Bain Capital Investors, and , citing alleged securities violations relate...

Pfizer Involved In Lawsuit Over US$45 Per Share Cerevel Acquisition
TipRanks 2d
Pfizer Faces Stock Slump Amidst Regulatory Challenges

Pfizer ( (PFE) ) has fallen by -9.35%. Read on to learn why. Pfizer’s stock has experienced a significant decline of 9.35% over the past week, reflecting a cha...

Benzinga 5d
UK's Health Agency Endorses Pfizer's Blood Cancer Combo Therapy As First For Untreated Hodgkin Lymphoma Patients

The U.K’s National Institute for Health and Care Excellence (NICE) on Wednesday recommended Pfizer Inc’s PFE Adcetris (brentuximab vedotin) for adult patients w...

UK's Health Agency Endorses Pfizer's Blood Cancer Combo Therapy As First For Untreated Hodgkin Lymphoma Patients

Analyst ratings

54%

of 24 ratings
Buy
41.7%
Hold
54.2%
Sell
4.2%

More PFE News

Simply Wall St 6d
Pfizer Expands RSV Vaccine Use In Europe Amid 3% Share Price Dip

recently saw the European Commission expand the authorization for its RSV vaccine, ABRYSVO, to include younger adults, and announced a collaboration with Flagsh...

Pfizer Expands RSV Vaccine Use In Europe Amid 3% Share Price Dip
TipRanks 6d
Potential Stock Woe Ahead as Pfizer Riles Donald Trump

Pfizer’s (PFE) stock has fallen ill since the COVID-19 pandemic waned, and it is still experiencing some aftereffects. The pharmaceutical giant, best known for...

TipRanks 6d
Pfizer announces European Commission approval of Abrysvo indication extension

Pfizer (PFE) announced that the European Commission has issued a decision amending the marketing authorization for Abrysvo, the company’s bivalent respiratory s...

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.